Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest Expenses (2020 - 2025)

RxSight (RXST) has disclosed Interest Expenses for 6 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 20.0% year-over-year to $4000.0, compared with a TTM value of $19000.0 through Dec 2025, down 13.64%, and an annual FY2025 reading of $19000.0, down 9.52% over the prior year.
  • Interest Expenses was $4000.0 for Q4 2025 at RxSight, roughly flat from $4000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.6 million in Q2 2023 and bottomed at $3000.0 in Q4 2023.
  • Average Interest Expenses over 5 years is $598850.0, with a median of $464000.0 recorded in 2021.
  • The sharpest move saw Interest Expenses soared 35866.67% in 2021, then tumbled 99.79% in 2023.
  • Year by year, Interest Expenses stood at $1.1 million in 2021, then surged by 34.48% to $1.5 million in 2022, then crashed by 99.79% to $3000.0 in 2023, then surged by 66.67% to $5000.0 in 2024, then decreased by 20.0% to $4000.0 in 2025.
  • Business Quant data shows Interest Expenses for RXST at $4000.0 in Q4 2025, $4000.0 in Q3 2025, and $5000.0 in Q2 2025.